Induced Abortion
Return to Library
|
Free Induced Abortion Articles |
|
|
|
|
Reports outline obstetrics and gynecology research from Harvard University
2009 JUN 11 - (NewsRx.com) -- According to recent research published in the Bjog - an International Journal of Obstetrics and Gynaecology, "To assess the comparative health and economic outcomes associated with three alternative first-trimester abortion techniques in Mexico City and to examine the policy implications of increasing access to safe abortion modalities within a restrictive setting. Cost-effectiveness analysis. Mexico City. Reproductive-aged women with unintended pregnancy seeking first-trimester abortion." "Synthesising the best available data, a computer-based model simulates induced abortion and its potential complications and is used to assess the cost-effectiveness of alternative safe modalities for first-trimester pregnancy termination: (1) hospital-based dilatation and curettage (D&C), (2) hospital-based manual vacuum aspiration (MVA), (3) clinic-based MVA and (4) medical abortion using vaginal misoprostol. Number of complications, lifetime costs, life expectancy, quality-adjusted life expectancy. In comparison to the magnitude of health gains associated with all safe abortion modalities, the relative differences between strategies were more pronounced in terms of their economic costs. Assuming all options were equally available, clinic-based MVA was the least costly and most effective. Medical abortion with misoprostol provided comparable benefits to D&C, but cost substantially less. Enhanced access to safe abortion was always more influential than shifting between safe abortion modalities. This study demonstrates that the provision of safe abortion is cost-effective and will result in reduced complications, decreased mortality and substantial cost savings compared with unsafe abortion," wrote D. Hu and colleagues, Harvard University. The researchers concluded: "In Mexico City, shifting from a practice of hospital-based D&C to clinic-based MVA and enhancing access to medical abortion will have the best chance to minimise abortion-related morbidity and mortality." Hu and colleagues published their study in Bjog - an International Journal of Obstetrics and Gynaecology (Cost-effectiveness analysis of alternative first-trimester pregnancy termination strategies in Mexico City. Bjog - an International Journal of Obstetrics and Gynaecology, 2009;116(6):768-779). For additional information, contact D. Hu, Harvard University, School Public Health, Dept. of Health Policy & Management, Program Health Decis Science, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115, USA. The publisher's contact information for the Bjog - an International Journal of Obstetrics and Gynaecology is: Wiley-Blackwell Publishing, Inc., Commerce Place, 350 Main St., Malden 02148, MA, USA. Keywords: United States, Boston, Life Sciences, Induced Abortion, Surgery, Curettage, Obstetrics, Pregnancy, Misoprostol, Pharmaceuticals, Drugs, Therapy, Treatment, Gynecology, Obstetrics and Gynecology, Harvard University. This article was prepared by Hospital & Nursing Home Week editors from staff and other reports. Copyright 2009, Hospital & Nursing Home Week via NewsRx.com.
|
